Introductıon: We sought to determine the possible association of stroke risk prediction models (CHA2DS2-VASc, CHADS2) and the new R2CHADS2 (The inclusion of creatinine clearance (CrCL) <60 mL/min to CHADS2) to the markers of brain ischemia and inflammation such as hsCRP and Neutrophil to Lymphocyte Ratio (NLR) in patients with non-valvular atrial fibrillation (NVAF). We tested the hypothesis that markers of subclinical brain ischemia (NSE and S100b) are higher in patients with NVAF having higher stroke risk as determined by risk prediction models. Methods: The study population included 92 patients who were seen in our outpatient clinic. End-stage hepatic or renal disease, malignancy, any prior blood transfusions, carotid artery disease, prior transient ischemic attack and ischemic or hemorrhagical stroke and oral anticoagulant usage were excluded from study. Serum levels of S100B, NSE, hs-CRP were measured by using a commercial enzyme-linked immunoassay kits and each assay was carried out in duplicate. S100B, neuron specific enolase, NSE and Hs-CRP levels were determined by using sandwich ELISA kits (Human S100B ELISA kit, BioVendor Research and Diagnostic Products; DRG,NSE ELISA; DRG, HS-CRP).The minimal measurable concentrations for these detection systems were 50 pg/ml for S100B, 1 ng/ml for NSE, and 0.1 mg/L for Hs-CRP. Intra and inter assay variabilities for each marker were 4.4% and 11.2% for NSE, 7.5% and 4.1% for Hs-CRP and 3.8% and 10.1% for S100b. Results: The patients were divided into three group according to their CHA2DS2Vasc score as follows; score under <2, score 3-4,and score >4. There were no significant differences among the groups in terms of Hs-Rcp and NLR. We showed outstanding findings in NSE and S100b values that patients with CHA2DS2VASc scores higher than 4 had significantly higher values of brain damage marker than patients with the scores of below 2 (23.2 AE 15.8 ng/ml vs. 32.6 AE 28.9 ng/ml vs. 44.4 ng/ml AE 35.4 p¼0.022 and 161 AE 62 pg/ml vs.186 AE 37 pg/ml vs.189 AE 25 pg/ml p¼0.037,respectively). Serum levels of NSE and S100b were correlated with CHA2DS2Vasc scores (p¼0.04 r¼0.218 for NSE and p¼0.03 r¼0.229 for s100b). Aim: Interatrial block (IAB) connotes a P wave duration !110 msec on electrocardiography (ECG). P-terminal force corresponds to a biphasic P wave with its terminal negative phase !40 msec x mm in V1 derivation on ECG. IAB and P-terminal force are closely related parameters and they are accepted as predictors for left atrial dysfunction, left atrial dilatation, atrial fibrillation and strokes. Left atrial functions in chronic haemodialysis patients becomes worse in the course of time because of long standing pressure and volume overload. The aim of this study is to evaluate the relationship between IAB, P-terminal force and left atrial functions. Patients and Methods: 68 chronic haemodialysis patients and 60 control subjects were included in the study. Haemodialysis group had 42AE13.5 months dialysis period. Conventional echocardiography and left atrial dynamic functions were measured in all cases. The subjects with IAB and P-terminal force on ECG were identified.
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Relationship between Left Atrial Functions, P-terminal Aim: Interatrial block (IAB) connotes a P wave duration !110 msec on electrocardiography (ECG). P-terminal force corresponds to a biphasic P wave with its terminal negative phase !40 msec x mm in V1 derivation on ECG. IAB and P-terminal force are closely related parameters and they are accepted as predictors for left atrial dysfunction, left atrial dilatation, atrial fibrillation and strokes. Left atrial functions in chronic haemodialysis patients becomes worse in the course of time because of long standing pressure and volume overload. The aim of this study is to evaluate the relationship between IAB, P-terminal force and left atrial functions. Patients and Methods: 68 chronic haemodialysis patients and 60 control subjects were included in the study. Haemodialysis group had 42AE13.5 months dialysis period. Conventional echocardiography and left atrial dynamic functions were measured in all cases. The subjects with IAB and P-terminal force on ECG were identified. Results: Demographic, electrocardiographic and echocardiographic data of study and control groups is presented in Table 1 . Left ventricular size, wall thickness and left atrial diameters were significantly greater in haemodialysis patients than the control group (p<0.001). 42 (62%) patients had IAB (!110 msec) and 45 (66%) patients had P-terminal force (!40 msecxmm) in the haemodialysis group. Left atrial reservoir, conduit and pump functions were significantly lower in the haemodialysis group than the control group (p<0.001) ( Table 2) . Conclusıons: This study showed that decreased left atrial functions in chronic haemodialysis patients are closely correlated with IAB and P-terminal force. Results: There was no significant difference with respect to age and gender between groups. There was no statistical difference in genotype distribution among the groups. The genotype distribution in nonvalvuler AF who have had a stroke group was as follows: normal genotype (GG) frequency was 67 (95.7%) and heterozygous mutant genotype (GA) frequency was 3 (4.3%). The genotype distribution in control group was as follows: normal genotype (GG) frequency was 68 (97.1%) and heterozygous genotype (GA) frequency was 2 (2.9%). Homozygous genotype (AA) was not detected in both groups. There was no statistically significant difference betwen groups in genotype distributions. Conclusıons: Our results suggest that the Apo B R3500Q gene mutation appears not to be associated with nonvalvular AF with ischemic stroke in Turkish population.
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Increased Purpose: Lichen planus is a chronic, inflammatory, and autoimmune mucocutaneus disease. There has been recent research emphasis on the strong association between inflammation both P-wave dispersion and dyslipidemia. The differences between the maximum and the minimum P-wave duration on electrocardiogram are defined as Pwave dispersion. Prolongation of P-wave dispersion has been demonstrated to be an independent risk factor for the development of atrial fibrillation. The aim of this the study was to investigate P-wave dispersion in patients with lichen planus.
Methods: Fifty-eight patients with lichen planus and 37 age and sex-matched, healthy controls were included in this study. We obtained electrocardiographic recordings from all participants and used them to calculate P-wave variables. We also assessed high-sensitive C-reactive proteins that an inflammatory marker and the lipid levels for each group. Results were reported as means AE standard deviations and percentages. Results: P-wave dispersion were significantly higher in lichen planus patients than in the control group (39.9AE12.9 ms, versus 32.4AE11.8 ms, p¼0.005, respectively). Also, highsensitive C-reactive proteins (3.5AE2.6, versus 1.7AE1.1, p<0.001), versus 96.8AE33.6, p<0.001) and, triglyceride (169.2AE93.6, versus 110.5AE52.7, p¼0 .001)levels were significantly higher in patients with lichen planus, compared to controls. There was a significant, positive correlation between highsensitive C-reactive proteins and P-wave dispersion (r¼0.549, p<0.001) in lichen planus patients. Conclusıons: P-wave dispersion increased on surface electrocardiographic measurements in lichen planus patients. This result may be important in early detection of subclinical cardiac involvement. Increased P-wave dispersion should be considered, in terms of tendency to atrial fibrillation, in these patients. 
